Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

NCT00501332 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Neutropenia
Breast Cancer

Interventions

BIOLOGICAL: Maxy-G34

Sponsor

Maxygen Holdings Ltd.

Collaborators

[object Object]
[object Object]
[object Object]